院内感染管理の世界市場2020-2025

◆英語タイトル:Hospital Acquired Infection Control Market - Growth, Trends, and Forecast (2020 - 2025)
◆商品コード:MOR2011043
◆発行会社(リサーチ会社):Mordor Intelligence
◆発行日:2020年10月
◆ページ数:124
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD4,250 ⇒換算¥459,000見積依頼/購入/質問フォーム
Team User(5名利用)USD4,750 ⇒換算¥513,000見積依頼/購入/質問フォーム
Corporate License(法人利用)USD6,000 ⇒換算¥648,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMordor Intelligence社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Mordor Intelligence社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、院内感染管理の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別(滅菌剤、消毒剤、その他)分析、疾患別(院内肺炎、菌血症、手術部位感染症、胃腸感染症、尿路感染症)分析、エンドユーザー別(病院・集中治療室、外来手術・診断センター、ナーシングホーム・マタニティセンター)分析、地域別分析、競争状況、市場機会・将来分析などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・院内感染管理の世界市場規模:製品別(滅菌剤、消毒剤、その他)
・院内感染管理の世界市場規模:疾患別(院内肺炎、菌血症、手術部位感染症、胃腸感染症、尿路感染症)
・院内感染管理の世界市場規模:エンドユーザー別(病院・集中治療室、外来手術・診断センター、ナーシングホーム・マタニティセンター)
・院内感染管理の世界市場規模:地域別
・競争状況
・市場機会・将来分析
【レポートの概要】

The hospital acquired infection control market is expected to witness a CAGR of 7.3% during the forecast period. Certain factors that have been driving the market growth include the increase in hospital stay due to chronic diseases and surgeries, a rise in the incidences of different types of hospital-acquired infections, and innovative technologies implemented in devices that control infection.
• Hospital acquired infections are usually caused by pathogens, which spread at a very fast rate in the body. Due to the patients’ weak immune system and poor conditions in a hospital, the infections spread at a greater speed than the normal infections.
• These infections have been treated by taking antibiotics, by following a proper and healthy diet, and by encouraging the natural healing process. The infection can be prevented by keeping the hospital facility premises clean.
• The most common type of hospital acquired infections is a urinary tract infection. The increase in incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital-acquired infections are some of the factors that have been driving the growth of the studied market.

[Key Market Trends]
Disinfectant is Expected to Hold Significant Market Share in the Product Type
Disinfection is referred to as a process, which eliminates many or all pathogenic microorganisms, except the bacterial spores from inanimate objects. This is accomplished by the use of liquid chemicals or wet pasteurization. The efficiency of disinfection has been affected by several factors, each of which may limit the efficacy of the process. Some of the factors, which have been shown to affect disinfection efficacy are the earlier cleaning of the object, the organic load on the item, the type and level of microbial impurity, the physical configuration of the object (e.g., crevices, hinges, and lumens), the concentration of exposure time to the germicide, and the pH and temperature of the disinfection process. The US FDA (Food and Drug Administration) maintains a list of high-level disinfectants that can be used to reprocess heat-sensitive medical devices, such as flexible endoscopes.

[North America Dominates the Market and Expected to do Same in the Forecast Period]
According to the Centers for Disease Control and Prevention (CDC), even though significant progress has been made in stopping some healthcare-associated infection types from spreading, there is still much more work to be done. On any given day, in the United States, around one in 31 hospital patients has at least one healthcare-associated infection. North America, especially the United States and Canada, has made significant progress toward the collective goal of abolishing these HAIs, and as a result, healthcare in this region has become safer now than it was even 10 years ago. Building upon this success and continuing toward the elimination of hospital-acquired infections is critical, and this has contributed to the largest market share of North America.

[Competitive Landscape]
The hospital acquired infection control market is highly competitive and consists of several players. Companies, like 3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux Sa, Cantel Medical, Ethicon, Getinge Group, Kimberly-Clark Corporation, Sterigenics International LLC, and Steris Corporation, among others, hold the substantial market share in the hospital acquired infection control market.

[Reasons to Purchase this report]
• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

【レポートの目次】

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Hospital Stay Due to Chronic Diseases and Surgeries
4.2.2 Rise in the Incidences of Different Types of Hospital Acquired Infections
4.2.3 Innovative Technologies Implemented in Devices that Control Infection
4.3 Market Restraints
4.3.1 Lack of Awareness Regarding Hospital Acquired Infection
4.3.2 Stringent Regulatory Requirements
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product
5.1.1 Sterilants
5.1.1.1 Heat Sterilization Equipment
5.1.1.2 Low Temperature Sterilization Equipment
5.1.1.3 Radiation Sterilization Equipment
5.1.1.4 Steam Sterilization
5.1.1.5 Other Sterilants
5.1.2 Disinfectants
5.1.3 Other Products
5.2 Indication
5.2.1 Hospital Acquired Pneumonia
5.2.2 Bloodstream Infections
5.2.3 Surgical Site Infections
5.2.4 Gastrointestinal Infections
5.2.5 Urinary Tract Infections
5.2.6 Other Indications
5.3 End User
5.3.1 Hospitals and Intensive Care Units
5.3.2 Ambulatory Surgical and Diagnostic Centers
5.3.3 Nursing Homes and Maternity Centers
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M Company
6.1.2 Becton, Dickinson and Company
6.1.3 Fortive Corporation
6.1.4 Metall Zug Group (Belimed)
6.1.5 Cantel Medical
6.1.6 Getinge AB
6.1.7 Sotera Health
6.1.8 STERIS PLC
6.1.9 S. C. Johnson & Son Inc.
6.1.10 Tuttnauer
7 MARKET OPPORTUNITIES AND FUTURE TRENDS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[院内感染管理の世界市場2020-2025]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆